The effect of immunosuppressant FK506 on hepatic function of graft

免疫抑制剂FK506对移植物肝功能的影响

基本信息

  • 批准号:
    14571243
  • 负责人:
  • 金额:
    $ 2.18万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2002
  • 资助国家:
    日本
  • 起止时间:
    2002 至 2004
  • 项目状态:
    已结题

项目摘要

Studies were performed to determine whether the immunosuppressants FK506 and cyclosporin A directly influence gene expression of inducible nitric oxide synthase by IL-1β in hepatocytes. Methods : Primary cultures of rat hepatocytes were treated with IL-1β in the presence and absence of FK506 or cyclosporin A. Release of nitrite into culture medium, levels of inducible nitric oxide synthase protein and mRNA, and activation of NF-κB were compared with the two drugs. Results : IL-1β increased levels of inducible nitric oxide synthase protein and inducible nitric oxide synthase mRNA, as well as nitric oxide production, in the cultured hepatocytes. NF-κB, an important transcription factor in inducible nitric oxide synthase gene expression in response to inflammation, also appeared in the nuclear fraction of hepatocytes after addition of IL-1β. FK506 markedly inhibited the nitric oxide formation, inducible nitric oxide synthase protein synthesis and inducible nitric oxide synthase mRNA expression induced by IL-1β, but cyclosporin A had no effects. Furthermore, FK506 inhibited NF-κB activation and decreased mRNA levels of the p50/p65 subunits of NF-κB. Conclusions : These results demonstrate that FK506, but not cyclosporin A, inhibits the induction of inducible nitric oxide synthase expression during NF-κB activation
研究了免疫抑制剂FK 506和环孢素A是否直接影响IL-1β诱导的肝细胞一氧化氮合酶基因表达。方法:原代培养的大鼠肝细胞经IL-1β处理后,加入或不加入FK 506或环孢菌素A。比较两种药物在培养液中亚硝酸盐的释放、诱导型一氧化氮合酶蛋白和mRNA水平以及NF-κB的活化。结果如下:IL-1β可增加培养肝细胞中诱导型一氧化氮合酶蛋白和诱导型一氧化氮合酶mRNA的水平,以及一氧化氮的产生。NF-κB是炎症反应诱导型一氧化氮合酶基因表达的重要转录因子,加入IL-1β后,NF-κ B也出现在肝细胞核部分。FK 506可显著抑制IL-1β诱导的NO生成、诱导型一氧化氮合酶蛋白合成及诱导型一氧化氮合酶mRNA表达,而环孢素A无此作用。此外,FK 506还可抑制NF-κB的活化,并降低NF-κB的p50/p65亚基的mRNA水平。结论:这些结果表明,在NF-κB活化过程中,FK 506而不是环孢菌素A抑制诱导型一氧化氮合酶表达的诱导

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAMIYAMA Yasuo其他文献

KAMIYAMA Yasuo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAMIYAMA Yasuo', 18)}}的其他基金

NEW LIVER SUPPORT SYSTEM USING EXVIVO PERFUSED LIVER
使用 EXVIVO 灌注肝脏的新型肝脏支持系统
  • 批准号:
    09671344
  • 财政年份:
    1997
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EXPERIMENTAL STUDIES ON AUXILIARY LIVER TRANSPLANTATION BASED ON REDOX THEORY
基于氧化还原理论的辅助肝移植实验研究
  • 批准号:
    05671099
  • 财政年份:
    1993
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

Mechanism of Cyclosporin A-Induced Gingival Overgrowth
环孢素A诱导牙龈过度生长的机制
  • 批准号:
    400104
  • 财政年份:
    2019
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Studentship Programs
New molecular genetic examination of the mechanism of cyclosporin A in the initial treatment for kawasaki disease
环孢素A初始治疗川崎病机制的新分子遗传学检查
  • 批准号:
    15K09696
  • 财政年份:
    2015
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Functional mechanism of IVIG and cyclosporin A therapy for IVIG-resistant Kawasaki disease
IVIG和环孢素A治疗IVIG耐药川崎病的作用机制
  • 批准号:
    26860821
  • 财政年份:
    2014
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8514740
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8535509
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
Cyclosporin A inhibits cell death of cornel endothelial cells by protecting mitochondrial membrane potential
环孢素A通过保护线粒体膜电位抑制角质内皮细胞死亡
  • 批准号:
    23792005
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8286175
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
Analysis of the molecular mode of action of Cyclosporin A in inflammatory bowel disease
环孢素A在炎症性肠病中的分子作用模式分析
  • 批准号:
    206965563
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
    Clinical Research Units
PRECLINICAL CYCLOSPORIN A THERAPY TRIALS FOR PEDIATRIC TBI
环孢菌素 A 治疗儿童 TBI 的临床前试验
  • 批准号:
    8042851
  • 财政年份:
    2011
  • 资助金额:
    $ 2.18万
  • 项目类别:
Topical Cyclosporin A Treatment for Psoriasis
局部环孢素 A 治疗牛皮癣
  • 批准号:
    6833055
  • 财政年份:
    2004
  • 资助金额:
    $ 2.18万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了